SANGIOVANNI TIMOTHY J. (VP, Corporate Controller) purchased 36.9% of their position (1.20K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $5.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/13/2023ACC: 0001437749-23-006278
Officer· VP, Corporate Controller
Since Oct 2018
+1.20K
Net shares
Net buyer
$5.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.20K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.10K
Price / share
$4.14
Trade value
$4.55K
% of position
33.9%
3/10/2023
3.25K→4.35K
Common Stock
Direct
Shares
+100.00
Price / share
$4.13
Trade value
$413.50
% of position
2.3%
3/10/2023
4.35K→4.45K
Total
Net shares
+1.20K
Net value
$4.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/10/2023 | P · Purchase | +1.10K | $4.14 | $4.55K | 33.9% | 3.25K | 4.35K |
| Common Stock Direct | 3/10/2023 | P · Purchase | +100.00 | $4.13 | $413.50 | 2.3% | 4.35K | 4.45K |
| Total | +1.20K | $4.97K | ||||||
Derivative Transactions0
No derivative transactions reported